Eli Lilly to buy gene therapy company Akouos for $487 million
Eli Lilly to buy gene therapy company Akouos for $487 million
Stay updated with breaking news from Emmanuel Simons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly to buy gene therapy company Akouos for $487 million
Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced a definitive agreement for Lilly to acquire Akouos, a precision genetic medicine company that is developing a portfolio of first-in-class adeno-associated viral gene therapies for the treatment of inner ear conditions, including ...
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced a definitive agreement for Lilly to acquire Akouos, a...
Akouos has an extensive portfolio, including gene therapies that can help with hearing loss.